Position in A
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$665,876
+$347,074 QoQ
Shares Held
5,013
+79.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#563
of 1,112 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026OXFORD ASSET MANAGEMENT LLP holds $2,686,479 across 7 Diagnostics & Research names. A ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
This page
|
5,013 | $665,876 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,074 | $565,396 | |
| 3 | DHR |
Danaher Corp /De/
|
2,351 | $447,818 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
1,610 | $311,084 | |
| 5 | NTRA |
Natera, Inc.
|
1,054 | $286,108 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
410 | $205,557 | |
| 7 | GH |
Guardant Health, Inc.
|
1,364 | $204,640 |
All Filings in A
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $665,876 | 5,013 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $318,802 | 2,797 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,313,483 | 9,653 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $337,019 | 2,881 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||